Presentation TCT 2016 The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI: Design, Rationale, and Status Presenter: Freek W.A. Verheugt, Pascal Vranckx, Roxana Mehran November 01, 2016